At AACR, Revolution Medicines presented more eye-catching data about its KRAS-targeting treatment, a...
At AACR, more strong results for Revolution Medicine's KRAS drug, plus assurance from NCI's director
At AACR, Revolution Medicines presented more eye-catching data about its KRAS-targeting treatment, and Anthony Letai declared the state of cancer research...
Author: statnews.com
Read Original Article